Low-carbohydrate diet in type 2 diabetes: stable improvement of bodyweight and glycemic control during 44 months follow-up

Jörgen V Nielsen, Eva A Joensson, Jörgen V Nielsen, Eva A Joensson

Abstract

Background: Low-carbohydrate diets, due to their potent antihyperglycemic effect, are an intuitively attractive approach to the management of obese patients with type 2 diabetes. We previously reported that a 20% carbohydrate diet was significantly superior to a 55-60% carbohydrate diet with regard to bodyweight and glycemic control in 2 groups of obese diabetes patients observed closely over 6 months (intervention group, n = 16; controls, n = 15) and we reported maintenance of these gains after 22 months. The present study documents the degree to which these changes were preserved in the low-carbohydrate group after 44 months observation time, without close follow-up. In addition, we assessed the performance of the two thirds of control patients from the high-carbohydrate diet group that had changed to a low-carbohydrate diet after the initial 6 month observation period. We report cardiovascular outcome for the low-carbohydrate group as well as the control patients who did not change to a low-carbohydrate diet.

Method: Retrospective follow-up of previously studied subjects on a low carbohydrate diet.

Results: The mean bodyweight at the start of the initial study was 100.6 +/- 14.7 kg. At six months it was 89.2 +/- 14.3 kg. From 6 to 22 months, mean bodyweight had increased by 2.7 +/- 4.2 kg to an average of 92.0 +/- 14.0 kg. At 44 months average weight has increased from baseline g to 93.1 +/- 14.5 kg. Of the sixteen patients, five have retained or reduced bodyweight since the 22 month point and all but one have lower weight at 44 months than at start. The initial mean HbA1c was 8.0 +/- 1.5%. After 6, 12 and 22 months, HbA1c was 6.1 +/- 1.0%, 7.0 +/- 1.3% and 6.9 +/- 1.1% respectively. After 44 months mean HbA1c is 6.8 +/- 1.3%.Of the 23 patients who have used a low-carbohydrate diet and for whom we have long-term data, two have suffered a cardiovascular event while four of the six controls who never changed diet have suffered several cardiovascular events.

Conclusion: Advice to obese patients with type 2 diabetes to follow a 20% carbohydrate diet with some caloric restriction has lasting effects on bodyweight and glycemic control.

Figures

Figure 1
Figure 1
Individual changes in bodyweight in 16 obese patients with type 2 diabetes. The patients at start changed from a high-carbohydrate diet to a diet consisting of 20% carbohydrates, 30% protein and 50% fat. The dotted red line is the mean weight.

References

    1. Westman EC, Yancy WS, Jr, Humphreys M. Dietary treatment of diabetes mellitus in the pre-insulin era (1914–1922) Perspect Biol Med. 2006;49:77–83. doi: 10.1353/pbm.2006.0017.
    1. American Diabetes Association Nutrition recommendations and interventions for diabetes. A position statement of the American Diabetes Association Diabetes Care. 2008;31:S61–S78.
    1. Boden G, Sargrad K, Homko C, Mozzoli M, Stein TP. Effects of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med. 2005;142:403–411.
    1. Gannon MC, Nuttall FQ. Effect of a high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabetes. Diabetes. 2004;53:2375–2382. doi: 10.2337/diabetes.53.9.2375.
    1. Nielsen JV, Jonsson E, Nilsson AK. Lasting improvements of hyperglycemia and bodyweight: low-carbohydrate diet in type 2 diabetes. Ups J Med Sci. 2005;110:179–83.
    1. Nielsen JV, Joensson E. Low-carbohydrate diet in type 2 diabetes. Stable improvement of bodyweight and glycemic control during 22 months follow-up. Nutr Metab (Lond) 2006;3:22. doi: 10.1186/1743-7075-3-22.
    1. Yancy WS, Jr, Foy M, Chalecki AM, Vernon MC, Westman EC. A low-carbohydrate, ketogenic diet to treat type 2 diabetes. Nutr Metab (Lond) 2005;2:34. doi: 10.1186/1743-7075-2-34.
    1. Friedman MI, Stricker EM. The physiological psychology of hunger: a physiological perspective. Psychological review. 1976;83:409–431. doi: 10.1037/0033-295X.83.6.409.
    1. Johnstone AM, Horgan GW, Murison SD, Bremner DM, Lobley GE. Effects of a high-protein ketogenic diet on hunger, appetite, and weight loss in obese men feeding ad libitum. Am J Clin Nutr. 2008;87:44–55.
    1. Pirozzo S, Summerbell C, Cameron C, Glasziou P. Advice on low-fat diets for obesity (review) Cochrane Library. 2007;2
    1. Samaha FF, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, Williams T, Gracely EJ, Stern L. A low-carbohydrate as compared with a low-fat diet in severe obesity. N Eng J Med. 2003;348:2074–81. doi: 10.1056/NEJMoa022637.
    1. Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS, Szapary PG, Rader DJ, Edman JS. A randomized trial of low-carbohydrate diet for obesity. N Eng J Med. 2003;348:2082–90. doi: 10.1056/NEJMoa022207.
    1. Brehm JB, Seeley RJ, Daniels SR, D'Alessio DA. A randomised trial comparing a very low carbohydrate diet and calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol. 2003;88:1617–1623. doi: 10.1210/jc.2002-021480.
    1. Sondike SB, Copperman N, Jacobson MS. Effects of a low-carbohydrate diet on weight loss and cardiovascular risk factors in overweight adolescents. J Pediatr. 2003;142:253–8. doi: 10.1067/mpd.2003.4.
    1. Yancy WS, Olsen MK, Guyton JR, Bakst RP, Westman EC. A low-carbohydrate ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia. Ann Int Med. 2004;140:769–777.
    1. Gardner CD, Kiazand A, Alhassan S, Kim S, Stafford R, Balise RR, Kraemer H, King AC. Comparison of the Atkins, Zone, Ornish, and Learn diets for change in weight and related risk factors among overweight premenopausal women. JAMA. 2007;297:969–977. doi: 10.1001/jama.297.9.969.
    1. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med. 1993;329:977–986. doi: 10.1056/NEJM199309303291401.
    1. The diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study research group Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Eng J Med. 2005;353:2643–2653. doi: 10.1056/NEJMoa052187.
    1. Stratton IM, Adler AL, Andrew H, Neil W, matthews D, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405–412. doi: 10.1136/bmj.321.7258.405.
    1. Volek JS, Feinman RD. Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction. Nutr Metab (Lond) 2005;2:31. doi: 10.1186/1743-7075-2-31.
    1. Accurso A, Bernstein RK, Dahlqvist A, Draznin B, Feinman RD, Fine EJ, Gleed A, Jacobs DB, Larson G, Lustig RH, Manninen AH, McFarlane SI, Morrison K, Nielsen JV, Ravnskov U, Roth KS, Silvestre R, Sowers JR, Sundberg R, Volek JS, Westman EC, Wood RJ, Wortman J, Vernon MC. Dietary carbohydrate restriction restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Nutr Metab (Lond) 2008;5:9. doi: 10.1186/1743-7075-5-9.

Source: PubMed

3
Abonnieren